Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis

Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients; however, controversy exists as to whether mortality in serious infections can be decreased through administration by prolonged infusion compared with intermittent infusion. The purpose of this systematic...

Full description

Bibliographic Details
Main Authors: Rhodes, Nathaniel J., Liu, Jiajun, O'Donnell, J. Nicholas, Dulhunty, Joel M., Abdul Aziz, Mohd. Hafiz, Berko, Patsy Y., Nadler, Barbara, Lipman, Jeffrey, Roberts, Jason A.
Format: Article
Language:English
English
English
Published: The Society of Critical Care Medicine and Wolters Kluwer Health, Inc. 2018
Subjects:
Online Access:http://irep.iium.edu.my/59246/
http://irep.iium.edu.my/59246/
http://irep.iium.edu.my/59246/
http://irep.iium.edu.my/59246/1/59246_Prolonged%20infusion%20piperacillin-tazobactam.pdf
http://irep.iium.edu.my/59246/2/59246_Prolonged%20infusion%20piperacillin-tazobactam_WOS.pdf
http://irep.iium.edu.my/59246/13/59246_Prolonged%20infusion%20piperacillin-tazobactam%20decreases%20mortality%20and%20improves_SCOPUS.pdf

Similar Items